These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 29608706)
1. Risks and outcomes of invasive fungal infections in pediatric allogeneic hematopoietic stem cell transplant recipients receiving fluconazole prophylaxis: a multicenter cohort study by the Turkish Pediatric Bone Marrow Transplantation Study Group. Hazar V; Karasu GT; Uygun V; Öztürk G; Kiliç SÇ; Küpesiz A; Daloglu H; Aksoylar S; Atay D; Ince EÜ; Karakükçü M; Özbek N; Tayfun F; Kansoy S; Özyürek E; Akçay A; Gürsel O; Haskologlu S; Kaya Z; Yilmaz S; Tanyeli A; Yesilipek A Med Mycol; 2019 Feb; 57(2):161-170. PubMed ID: 29608706 [TBL] [Abstract][Full Text] [Related]
2. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience. Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052 [TBL] [Abstract][Full Text] [Related]
3. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients. Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404 [TBL] [Abstract][Full Text] [Related]
4. Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children's hospital in Argentina. Gomez SM; Caniza M; Fynn A; Vescina C; Ruiz CD; Iglesias D; Sosa F; Sung L Transpl Infect Dis; 2018 Aug; 20(4):e12913. PubMed ID: 29679436 [TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation. Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797 [TBL] [Abstract][Full Text] [Related]
6. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling. Sarina B; Mariotti J; Bramanti S; Morabito L; Crocchiolo R; Rimondo A; Tordato F; Pocaterra D; Casari E; De Philippis C; Carlo-Stella C; Santoro A; Castagna L Transpl Infect Dis; 2018 Aug; 20(4):e12906. PubMed ID: 29668124 [TBL] [Abstract][Full Text] [Related]
7. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography. Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731 [TBL] [Abstract][Full Text] [Related]
8. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation. Busca A; Candoni A; Audisio E; Passera R; Bruno B; Monaco F; Mordini N; Vacca A; Delia M; Aversa F; Pagano L Biol Blood Marrow Transplant; 2016 Dec; 22(12):2214-2219. PubMed ID: 27667012 [TBL] [Abstract][Full Text] [Related]
9. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients. Miceli MH; Churay T; Braun T; Kauffman CA; Couriel DR Mycopathologia; 2017 Jun; 182(5-6):495-504. PubMed ID: 28124219 [TBL] [Abstract][Full Text] [Related]
11. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073 [TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis. Biyun L; Yahui H; Yuanfang L; Xifeng G; Dao W Clin Microbiol Infect; 2024 May; 30(5):601-610. PubMed ID: 38280518 [TBL] [Abstract][Full Text] [Related]
14. Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation. Christen D; Sohlbach K; Metzelder SK; Wollmer E; Hoeffkes HG; Naumann R; Burchardt A; Rummel M; Trenker C; Dohse M; Mack E; Klameth A; Mann C; Kostrewa P; Brendel C; Wündisch T; Neubauer A; Wilhelm C; Burchert A Leuk Lymphoma; 2019 Aug; 60(8):2056-2061. PubMed ID: 30644334 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients. Liu F; Wu T; Wang JB; Cao XY; Yin YM; Zhao YL; Lu DP Transpl Infect Dis; 2013 Jun; 15(3):243-50. PubMed ID: 23496156 [TBL] [Abstract][Full Text] [Related]
16. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877 [TBL] [Abstract][Full Text] [Related]
17. Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation. Hirade K; Kusumoto S; Hashimoto H; Shiraga K; Hagiwara S; Oiwa K; Suzuki T; Kinoshita S; Ri M; Komatsu H; Iida S Cancer Med; 2024 Feb; 13(3):e6815. PubMed ID: 38213090 [TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan. Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a primary antifungal prophylaxis protocol for preventing invasive mold infections after allogeneic hematopoietic stem cell transplantation. Herity LB; Cruz OA; Aziz MT J Oncol Pharm Pract; 2022 Jun; 28(4):794-804. PubMed ID: 33906508 [TBL] [Abstract][Full Text] [Related]